These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1283670)

  • 1. Preterm infants with patent ductus arteriosus: treatment with an enteral preparation of indomethacin.
    So LY; Fok TF; Sung RY; Ho JK
    Ann Trop Paediatr; 1992; 12(4):403-8. PubMed ID: 1283670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is oral indomethacin effective in treatment of preterm infants with patent ductus arteriosus?
    Satar M; Yapicioğlu H; Narli N; Ozbarlas N; Küçükosmanoğlu O; Tutak E
    Turk J Pediatr; 2004; 46(2):137-41. PubMed ID: 15214742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants.
    Chotigeat U; Jirapapa K; Layangkool T
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S563-9. PubMed ID: 14700149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus.
    Van Overmeire B; Smets K; Lecoutere D; Van de Broek H; Weyler J; Degroote K; Langhendries JP
    N Engl J Med; 2000 Sep; 343(10):674-81. PubMed ID: 10974130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late closure of the ductus arteriosus using indomethacin in the preterm infant.
    Kresch MJ; Moya FR; Ascuitto RJ; Ross-Ascuitto NT; Heusser F
    Clin Pediatr (Phila); 1988 Mar; 27(3):140-3. PubMed ID: 3342597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with intravenous indomethacin of symptomatic ductus arteriosus in premature newborn infants].
    Valls i Soler A; Benito J; Pastor E; López Heredia I; Santiago M; Cabrera A
    An Esp Pediatr; 1987 Aug; 27(2):112-6. PubMed ID: 3662265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.
    Supapannachart S; Limrungsikul A; Khowsathit P
    J Med Assoc Thai; 2002 Nov; 85 Suppl 4():S1252-8. PubMed ID: 12549803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous indomethacin therapy in preterm neonates with patent ductus arteriosus.
    Rajadurai VS; Yu VY
    J Paediatr Child Health; 1991 Dec; 27(6):370-5. PubMed ID: 1756081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic problems with indomethacin in preterm infants with persistent ductus arteriosus].
    Seyberth HW; Müller H; Wille L; Plückthun H; Ulmer HE; Wolf D
    Monatsschr Kinderheilkd; 1983 Feb; 131(2):71-6. PubMed ID: 6843560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants.
    Gouyon JB; Kibleur Y
    Clin Ther; 2010 Sep; 32(10):1740-8. PubMed ID: 21194597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing sulindac with indomethacin for closure of ductus arteriosus in preterm infants.
    Ng PC; So KW; Fok TF; Yam MC; Wong MY; Wong W
    J Paediatr Child Health; 1997 Aug; 33(4):324-8. PubMed ID: 9323621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parenteral indomethacin for closure of the patent ductus arteriosus. Clinical experience with 67 preterm infants.
    Harris JP; Merritt TA; Alexson CG; Longfield L; Manning JA
    Am J Dis Child; 1982 Nov; 136(11):1005-8. PubMed ID: 7124692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance of intravenous indomethacin treatment for premature infants with patent ductus arteriosus.
    Walters M
    BMJ; 1988 Sep; 297(6651):773-4. PubMed ID: 3142543
    [No Abstract]   [Full Text] [Related]  

  • 17. Tolerance to early human milk feeding is not compromised by indomethacin in preterm infants with persistent ductus arteriosus.
    Bellander M; Ley D; Polberger S; Hellström-Westas L
    Acta Paediatr; 2003 Sep; 92(9):1074-8. PubMed ID: 14599073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin treatment for symptomatic patent ductus arteriosus: a double-blind control study.
    Yanagi RM; Wilson A; Newfeld EA; Aziz KU; Hunt CE
    Pediatrics; 1981 May; 67(5):647-52. PubMed ID: 7019841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.